Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 136

1.

Changes in biomarkers in HIV-1-infected treatment-naive patients treated with tenofovir DF/emtricitabine plus atazanavir/ritonavir or lopinavir/ritonavir for 96 weeks: The CASTLE biomarker substudy.

Moyle G, Hardy H, Uy J, Ray N, Jimenez-Exposito MJ, McGrath D, Dejesus E.

Antivir Ther. 2014 Apr 16. doi: 10.3851/IMP2778. [Epub ahead of print]

PMID:
24739445
[PubMed - as supplied by publisher]
2.

Pharmacokinetics of the co-administration of boceprevir and St John's wort to male and female healthy volunteers.

Jackson A, D'Avolio A, Moyle G, Bonora S, Di Perri G, Else L, Simiele M, Singh GJ, Back D, Boffito M.

J Antimicrob Chemother. 2014 Jul;69(7):1911-5. doi: 10.1093/jac/dku060. Epub 2014 Mar 6.

PMID:
24610312
[PubMed - in process]
3.

Safety and efficacy of the peptide-based therapeutic vaccine for HIV-1, Vacc-4x: a phase 2 randomised, double-blind, placebo-controlled trial.

Pollard RB, Rockstroh JK, Pantaleo G, Asmuth DM, Peters B, Lazzarin A, Garcia F, Ellefsen K, Podzamczer D, van Lunzen J, Arastéh K, Schürmann D, Clotet B, Hardy WD, Mitsuyasu R, Moyle G, Plettenberg A, Fisher M, Fätkenheuer G, Fischl M, Taiwo B, Baksaas I, Jolliffe D, Persson S, Jelmert O, Hovden AO, Sommerfelt MA, Wendel-Hansen V, Sørensen B.

Lancet Infect Dis. 2014 Apr;14(4):291-300. doi: 10.1016/S1473-3099(13)70343-8. Epub 2014 Feb 11.

PMID:
24525316
[PubMed - indexed for MEDLINE]
4.

Coadministration of atazanavir-ritonavir and zinc sulfate: impact on hyperbilirubinemia and pharmacokinetics.

Moyle G, Else L, Jackson A, Back D, Yapa MH, Seymour N, Ringner-Nackter L, Karolia Z, Gazzard B, Boffito M.

Antimicrob Agents Chemother. 2013 Aug;57(8):3640-4. doi: 10.1128/AAC.00357-13. Epub 2013 May 20.

PMID:
23689708
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Cobicistat versus ritonavir as a pharmacoenhancer of atazanavir plus emtricitabine/tenofovir disoproxil fumarate in treatment-naive HIV type 1-infected patients: week 48 results.

Gallant JE, Koenig E, Andrade-Villanueva J, Chetchotisakd P, DeJesus E, Antunes F, Arastéh K, Moyle G, Rizzardini G, Fehr J, Liu Y, Zhong L, Callebaut C, Szwarcberg J, Rhee MS, Cheng AK.

J Infect Dis. 2013 Jul;208(1):32-9. doi: 10.1093/infdis/jit122. Epub 2013 Mar 26.

PMID:
23532097
[PubMed - indexed for MEDLINE]
Free Article
6.

NGX-4010, a capsaicin 8% patch, for the treatment of painful HIV-associated distal sensory polyneuropathy: integrated analysis of two phase III, randomized, controlled trials.

Brown S, Simpson DM, Moyle G, Brew BJ, Schifitto G, Larbalestier N, Orkin C, Fisher M, Vanhove GF, Tobias JK.

AIDS Res Ther. 2013 Jan 28;10(1):5. doi: 10.1186/1742-6405-10-5.

PMID:
23351618
[PubMed]
Free PMC Article
7.

Tenofovir, emtricitabine intracellular and plasma, and efavirenz plasma concentration decay following drug intake cessation: implications for HIV treatment and prevention.

Jackson A, Moyle G, Watson V, Tjia J, Ammara A, Back D, Mohabeer M, Gazzard B, Boffito M.

J Acquir Immune Defic Syndr. 2013 Mar 1;62(3):275-81. doi: 10.1097/QAI.0b013e3182829bd0.

PMID:
23274933
[PubMed - indexed for MEDLINE]
8.

Screening for chronic comorbid diseases in people with HIV: the need for a strategic approach.

Peters B, Post F, Wierzbicki AS, Phillips A, Power L, Das S, Johnson M, Moyle G, Hughes L, Wilkins E, McCloskey E, Compston J, Di Angelantonio E.

HIV Med. 2013 Jan;14 Suppl 1:1-11. doi: 10.1111/j.1468-1293.2012.01055.x. Review.

PMID:
23121515
[PubMed - indexed for MEDLINE]
9.

CCR5 antagonism impacts vaccination response and immune profile in HIV-1 infection.

Westrop SJ, Moyle G, Jackson A, Nelson M, Mandalia S, Imami N.

Mol Med. 2012 Oct 24;18:1240-8. doi: 10.2119/molmed.2012.00206.

PMID:
22875102
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Longer prior exposure to zidovudine/lamivudine-containing combination antiretroviral therapy, age, and male gender are each associated with reduced subcutaneous adipose tissue.

Vrouenraets SM, Wit FW, Garcia EF, Huber M, Brinkman K, Moyle G, Domingo P, Tarr PE, Podzamczer D, Ristola M, Gatell JM, Livrozet JM, Furrer H, Reiss P; PREPARE Study Group.

HIV Clin Trials. 2012 Mar-Apr;13(2):103-10. doi: 10.1310/hct1302-103.

PMID:
22510357
[PubMed - indexed for MEDLINE]
11.

Clinical significance of hyperbilirubinemia among HIV-1-infected patients treated with atazanavir/ritonavir through 96 weeks in the CASTLE study.

McDonald C, Uy J, Hu W, Wirtz V, Juethner S, Butcher D, McGrath D, Farajallah A, Moyle G.

AIDS Patient Care STDS. 2012 May;26(5):259-64. doi: 10.1089/apc.2011.0092. Epub 2012 Mar 9.

PMID:
22404426
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Room for manoeuvre when prescribing statins to dyslipidaemic patients on antiretroviral therapy.

Myers J, Rayment M, Sonecha S, Moyle G, Boffito M.

HIV Med. 2012 Mar;13(3):190-2. doi: 10.1111/j.1468-1293.2011.00957.x. No abstract available.

PMID:
22296166
[PubMed - indexed for MEDLINE]
13.

Pharmacokinetics of abacavir and its anabolite carbovir triphosphate without and with darunavir/ritonavir or raltegravir in HIV-infected subjects.

Jackson A, Moyle G, Dickinson L, Back D, Khoo S, Taylor J, Gedela K, Abongomera G, Gazzard B, Boffito M.

Antivir Ther. 2012;17(1):19-24. doi: 10.3851/IMP1910.

PMID:
22267465
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

The effect of a 12-week course of omega-3 polyunsaturated fatty acids on lipid parameters in hypertriglyceridemic adult HIV-infected patients undergoing HAART: a randomized, placebo-controlled pilot trial.

Peters BS, Wierzbicki AS, Moyle G, Nair D, Brockmeyer N.

Clin Ther. 2012 Jan;34(1):67-76. doi: 10.1016/j.clinthera.2011.12.001. Epub 2011 Dec 31.

PMID:
22212377
[PubMed - indexed for MEDLINE]
15.

A randomized, double-blind, controlled study of NGX-4010, a capsaicin 8% dermal patch, for the treatment of painful HIV-associated distal sensory polyneuropathy.

Clifford DB, Simpson DM, Brown S, Moyle G, Brew BJ, Conway B, Tobias JK, Vanhove GF; NGX-4010 C119 Study Group.

J Acquir Immune Defic Syndr. 2012 Feb 1;59(2):126-33. doi: 10.1097/QAI.0b013e31823e31f7.

PMID:
22067661
[PubMed - indexed for MEDLINE]
16.

T-cell signalling in antiretroviral-treated, aviraemic HIV-1-positive individuals is present in a raised state of basal activation that contributes to T-cell hyporesponsiveness.

Downey JS, Attaf M, Moyle G, Gazzard B, Gotch F, Imami N.

AIDS. 2011 Oct 23;25(16):1981-6. doi: 10.1097/QAD.0b013e32834b35a9.

PMID:
21811141
[PubMed - indexed for MEDLINE]
17.

Abacavir use and cardiovascular disease events: a meta-analysis of published and unpublished data.

Cruciani M, Zanichelli V, Serpelloni G, Bosco O, Malena M, Mazzi R, Mengoli C, Parisi SG, Moyle G.

AIDS. 2011 Oct 23;25(16):1993-2004. doi: 10.1097/QAD.0b013e328349c6ee. Review.

PMID:
21716077
[PubMed - indexed for MEDLINE]
18.

Pharmacokinetics of once-daily darunavir-ritonavir and atazanavir-ritonavir over 72 hours following drug cessation.

Boffito M, Jackson A, Amara A, Back D, Khoo S, Higgs C, Seymour N, Gazzard B, Moyle G.

Antimicrob Agents Chemother. 2011 Sep;55(9):4218-23. doi: 10.1128/AAC.01747-10. Epub 2011 Jun 27.

PMID:
21709075
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Sequential population pharmacokinetic modeling of lopinavir and ritonavir in healthy volunteers and assessment of different dosing strategies.

Dickinson L, Boffito M, Back D, Else L, von Hentig N, Davies G, Khoo S, Pozniak A, Moyle G, Aarons L.

Antimicrob Agents Chemother. 2011 Jun;55(6):2775-82. doi: 10.1128/AAC.00887-10. Epub 2011 Mar 21.

PMID:
21422211
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Pharmacokinetics and safety of the co-administration of the antiretroviral raltegravir and the lipid-lowering drug ezetimibe in healthy volunteers.

Jackson A, D'Avolio A, Watson V, Bonora S, Back D, Taylor J, Armenis K, Gazzard B, Moyle G, Boffito M.

J Antimicrob Chemother. 2011 Apr;66(4):885-9. doi: 10.1093/jac/dkq546. Epub 2011 Jan 22.

PMID:
21393207
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk